GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Sasaki, Motoko ^a   Matsubara, Takashi ^a   Nitta, Takeo ^a   Sato, Yasunori ^a   Nakanuma, Yasuni ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; K RAS PROTEIN; MUCIN 1; MUCIN 2; MUCIN 5AC; MUCIN 5B; MUCIN 6;

ADULT; AGED; ARTICLE; BILE DUCT TUMOR; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GNAS GENE; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY NEOPLASMS OF THE BILE DUCT; MALE; MIDDLE AGED; MISSENSE MUTATION; MOLECULAR PATHOLOGY; ONCOGENE K RAS; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; TUMOR VOLUME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MALE; MIDDLE AGED; MUCINS; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 84891458825     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081706     Document Type: Article

References (29)

1. Nakanuma Y, Curado M, Fransceschi S, Gores G, Paradis V, et al. (2010) Intrahepatic cholagiocarcinoma. In: Bosman F, Carneiro F, Hruban H, Theise N, editors. WHO classification of tumours of the digestive system 4th ed. ed. Lyon: IARC. pp. 217-227.
2. Rocha FG, Lee H, Katabi N, DeMatteo RP, Fong Y, et al. (2012) Intraductal papillary neoplasm of the bile duct: a biliary equivalent to intraductal papillary mucinous neoplasm of the pancreas? Hepatology 56: 1352-1360.
3. Nakanuma Y (2010) A novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas? Pathol Int 60: 419-429.
4. Ohtsuka M, Kimura F, Shimizu H, Yoshidome H, Kato A, et al. (2011) Similarities and differences between intraductal papillary tumors of the bile duct with and without macroscopically visible mucin secretion. Am J Surg Pathol 35: 512-521.
5. Shibahara H, Tamada S, Goto M, Oda K, Nagino M, et al. (2004) Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms. Am J Surg Pathol 28: 327-338. (Pubitemid 38269566)
6. Kim HJ, Kim MH, Lee SK, Yoo KS, Park ET, et al. (2000) Mucinhypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas. Endoscopy 32: 389-393. (Pubitemid 30219156)
7. Ishikawa A, Sasaki M, Ohira S, Ohta T, Oda K, et al. (2004) Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 84: 629-638. (Pubitemid 38858472)
8. Sasaki M, Matsubara T, Yoneda N, Nomoto K, Tsuneyama K, et al. (2013) Overexpression of enhancer of zeste homolog 2 and MUC1 may be related to malignant behaviour in intraductal papillary neoplasm of the bile duct. Histopathology 62: 446-457.
9. Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, et al. (2011) Wholeexome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 1: 161.
10. Wu J, Matthaei H, Maitra A, Dal Molin M, Wood LD, et al. (2011) Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 3: 92ra66.
11. Yamada M, Sekine S, Ogawa R, Taniguchi H, Kushima R, et al. (2012) Frequent activating GNAS mutations in villous adenoma of the colorectum. J Pathol 228: 113-118.
12. Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, et al. (2013) Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. J Pathol 229: 579-587.
13. Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, et al. (2012) Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 44: 690-693.
14. Hsu M, Sasaki M, Igarashi S, Sato Y, Nakanuma Y (2013) KRAS and GNAS mutations and p53 overexpression in biliary intraepithelial neoplasia and intrahepatic cholangiocarcinomas. Cancer 119: 1669-1674.
15. Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, et al. (2012) GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct. HPB (Oxford) 14: 677-683.
16. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, et al. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554.
17. Kanda M, Matthaei H, Wu J, Hong SM, Yu J, et al. (2012) Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia. Gastroenterology 142: 730-733 e739.
18. Nakanuma Y, Sasaki M (1989) Expression of blood-group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases. Hepatology 10: 174-178. (Pubitemid 19190207)
19. IUAC (2009) TNM Classification of Malignant Tumours. West Sussex: Wiley-Blackwell.
20. Sasaki M, Yamaguchi J, Itatsu K, Ikeda H, Nakanuma Y (2008) Overexpression of polycomb group protein EZH2 relates to decreased expression of p16 INK4a in cholangiocarcinogenesis in hepatolithiasis. J Pathol 215: 175-183. (Pubitemid 351786036)
21. Nishikawa G, Sekine S, Ogawa R, Matsubara A, Mori T, et al. (2013) Frequent GNAS mutations in low-grade appendiceal mucinous neoplasms. Br J Cancer108: 951-958.
22. Nault JC, Fabre M, Couchy G, Pilati C, Jeannot E, et al. (2012) GNASactivating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation. J Hepatol 56: 184-191.
23. Freda PU, Chung WK, Matsuoka N, Walsh JE, Kanibir MN, et al. (2007) Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission. Pituitary 10: 275-282. (Pubitemid 350055039)
24. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, et al. (1989) GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692-696. (Pubitemid 19214389)
25. Abraham SC, Lee JH, Hruban RH, Argani P, Furth EE, et al. (2003) Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract. Hum Pathol 34: 902-910. (Pubitemid 37169620)
26. Sasaki M, Ikeda H, Nakanuma Y (2007) Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem 42: 61-110. (Pubitemid 47007727)
27. Sasaki M, Nakanuma Y, Kim Y (1996) Characterization of apomicin expression in intrahepatic cholangio-carcinomas ans their precursor lesions: an immunohistochemical study. Hepatol 24: 1074-1078. (Pubitemid 26365906)
28. Round AN, Rigby NM, Garcia de la Torre A, Macierzanka A, Mills EN, et al. (2012) Lamellar structures of MUC2-rich mucin: a potential role in governing the barrier and lubricating functions of intestinal mucus. Biomacromolecules 13: 3253-3261.
29. Round AN, McMaster TJ, Miles MJ, Corfield AP, Berry M (2007) The isolated MUC5AC gene product from human ocular mucin displays intramolecular conformational heterogeneity. Glycobiology 17: 578-585. (Pubitemid 47062702)